Inflammatory bowel diseases and cannabinoids
1 matching public articles
Candidate association · not a treatment claimLoading compound profile…
Loading compound profile…
Synthetic cannabinoids
A carbobicyclic compound that is bicyclo[3.1.1]hept-2-ene which is substituted by a hydroxymethyl group at position 2, a 2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl group at position 4, and two methyl groups at position 6 (the 1<i>S</i>,4<i>S</i>,5<i>S</i> stereoisomer). A highly selective and effective cannabinoid type-2 agonist and the enantiomer of HU-433.
Definition: CHEBI:146244 · Chemical Entities of Biological Interest · release 253
Identity & provenance
C27H42O3 · molecular weight 414.63
Sources: ChEBI · 253PubChem computed properties · pug-260ec36a5ca8575c
0 referenced plant-occurrence records. They are identity candidates, not clinical evidence.
Research areas
Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.
1 matching public articles
Candidate association · not a treatment claimLinked local records
Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.
0 exact source-intervention matches.
No registered study intervention matched.
Latest documents